MDA (UK Medical Devices Agency) plans for growing regulatory enforcement remit
This article was originally published in Clinica
The UK Medical Devices Agency (MDA) expects its workload to continue expanding over the coming year, especially in the field of regulatory enforcement. According to its business plan for 2000-01, the primary drivers of this trend will be the extension of manufacturer registration requirements, expansion of the audit programme of UK notified bodies to include those involved with new regulations for in vitro diagnostic devices (IVDs) and an increase in the number of alleged breaches of the medical devices regulations.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.